nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CA8—endometrium—polycystic ovary syndrome	0.0103	0.024	CbGeAlD
Zonisamide—SCN1B—adipose tissue—polycystic ovary syndrome	0.00983	0.023	CbGeAlD
Zonisamide—SCN4B—adrenal cortex—polycystic ovary syndrome	0.00959	0.0224	CbGeAlD
Zonisamide—CA10—pituitary gland—polycystic ovary syndrome	0.00947	0.0221	CbGeAlD
Zonisamide—CA8—pituitary gland—polycystic ovary syndrome	0.00928	0.0217	CbGeAlD
Zonisamide—CA8—adipose tissue—polycystic ovary syndrome	0.00925	0.0216	CbGeAlD
Zonisamide—SCN3B—pituitary gland—polycystic ovary syndrome	0.00911	0.0213	CbGeAlD
Zonisamide—SCN3B—adipose tissue—polycystic ovary syndrome	0.00908	0.0212	CbGeAlD
Zonisamide—SCN1B—adrenal gland—polycystic ovary syndrome	0.00882	0.0206	CbGeAlD
Zonisamide—CA8—adrenal gland—polycystic ovary syndrome	0.00829	0.0194	CbGeAlD
Zonisamide—CA11—adrenal cortex—polycystic ovary syndrome	0.00826	0.0193	CbGeAlD
Zonisamide—SCN3B—adrenal gland—polycystic ovary syndrome	0.00814	0.019	CbGeAlD
Zonisamide—CA13—adipose tissue—polycystic ovary syndrome	0.00791	0.0185	CbGeAlD
Zonisamide—SCN4B—pituitary gland—polycystic ovary syndrome	0.00775	0.0181	CbGeAlD
Zonisamide—SCN4B—adipose tissue—polycystic ovary syndrome	0.00772	0.018	CbGeAlD
Zonisamide—SCN3B—vagina—polycystic ovary syndrome	0.00755	0.0176	CbGeAlD
Zonisamide—CYP2C19—urine—polycystic ovary syndrome	0.00755	0.0176	CbGeAlD
Zonisamide—CA11—endometrium—polycystic ovary syndrome	0.00737	0.0172	CbGeAlD
Zonisamide—CA10—endocrine gland—polycystic ovary syndrome	0.00733	0.0171	CbGeAlD
Zonisamide—CA13—adrenal gland—polycystic ovary syndrome	0.0071	0.0166	CbGeAlD
Zonisamide—SCN4B—adrenal gland—polycystic ovary syndrome	0.00692	0.0162	CbGeAlD
Zonisamide—CA11—uterus—polycystic ovary syndrome	0.00679	0.0159	CbGeAlD
Zonisamide—CA11—pituitary gland—polycystic ovary syndrome	0.00667	0.0156	CbGeAlD
Zonisamide—CA11—adipose tissue—polycystic ovary syndrome	0.00664	0.0155	CbGeAlD
Zonisamide—CA13—female gonad—polycystic ovary syndrome	0.00662	0.0155	CbGeAlD
Zonisamide—CA13—vagina—polycystic ovary syndrome	0.00658	0.0154	CbGeAlD
Zonisamide—SCN4B—vagina—polycystic ovary syndrome	0.00642	0.015	CbGeAlD
Zonisamide—CA13—endocrine gland—polycystic ovary syndrome	0.00615	0.0144	CbGeAlD
Zonisamide—CA11—adrenal gland—polycystic ovary syndrome	0.00596	0.0139	CbGeAlD
Zonisamide—CA11—female gonad—polycystic ovary syndrome	0.00556	0.013	CbGeAlD
Zonisamide—CA11—vagina—polycystic ovary syndrome	0.00552	0.0129	CbGeAlD
Zonisamide—CA5A—endocrine gland—polycystic ovary syndrome	0.00517	0.0121	CbGeAlD
Zonisamide—CA11—endocrine gland—polycystic ovary syndrome	0.00517	0.0121	CbGeAlD
Zonisamide—CYP3A4—urine—polycystic ovary syndrome	0.00446	0.0104	CbGeAlD
Zonisamide—Blood disorder—Metformin—polycystic ovary syndrome	0.00437	0.0444	CcSEcCtD
Zonisamide—CA3—uterus—polycystic ovary syndrome	0.00415	0.00969	CbGeAlD
Zonisamide—Accidental injury—Metformin—polycystic ovary syndrome	0.00412	0.0419	CcSEcCtD
Zonisamide—CA3—pituitary gland—polycystic ovary syndrome	0.00407	0.00951	CbGeAlD
Zonisamide—CA3—adipose tissue—polycystic ovary syndrome	0.00405	0.00948	CbGeAlD
Zonisamide—SCN9A—pituitary gland—polycystic ovary syndrome	0.00362	0.00847	CbGeAlD
Zonisamide—SCN9A—adipose tissue—polycystic ovary syndrome	0.00361	0.00843	CbGeAlD
Zonisamide—CACNA1H—uterus—polycystic ovary syndrome	0.00346	0.00808	CbGeAlD
Zonisamide—Neuropathy—Metformin—polycystic ovary syndrome	0.00342	0.0348	CcSEcCtD
Zonisamide—CACNA1H—pituitary gland—polycystic ovary syndrome	0.00339	0.00793	CbGeAlD
Zonisamide—CA3—vagina—polycystic ovary syndrome	0.00337	0.00788	CbGeAlD
Zonisamide—CA14—adrenal gland—polycystic ovary syndrome	0.0033	0.00772	CbGeAlD
Zonisamide—SCN9A—adrenal gland—polycystic ovary syndrome	0.00324	0.00756	CbGeAlD
Zonisamide—SCN4A—pituitary gland—polycystic ovary syndrome	0.00323	0.00755	CbGeAlD
Zonisamide—SCN4A—adipose tissue—polycystic ovary syndrome	0.00322	0.00752	CbGeAlD
Zonisamide—CA3—endocrine gland—polycystic ovary syndrome	0.00315	0.00737	CbGeAlD
Zonisamide—CACNA1H—adrenal gland—polycystic ovary syndrome	0.00303	0.00709	CbGeAlD
Zonisamide—CA9—endocrine gland—polycystic ovary syndrome	0.00302	0.00706	CbGeAlD
Zonisamide—AOX1—adrenal cortex—polycystic ovary syndrome	0.00298	0.00696	CbGeAlD
Zonisamide—SCN4A—adrenal gland—polycystic ovary syndrome	0.00289	0.00675	CbGeAlD
Zonisamide—Injury—Metformin—polycystic ovary syndrome	0.00288	0.0293	CcSEcCtD
Zonisamide—SCN2A—pituitary gland—polycystic ovary syndrome	0.00286	0.00668	CbGeAlD
Zonisamide—CACNA1H—female gonad—polycystic ovary syndrome	0.00283	0.00661	CbGeAlD
Zonisamide—MAOB—embryo—polycystic ovary syndrome	0.0028	0.00654	CbGeAlD
Zonisamide—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00271	0.0276	CcSEcCtD
Zonisamide—AOX1—endometrium—polycystic ovary syndrome	0.00266	0.00621	CbGeAlD
Zonisamide—CACNA1H—endocrine gland—polycystic ovary syndrome	0.00263	0.00615	CbGeAlD
Zonisamide—CA5B—adipose tissue—polycystic ovary syndrome	0.00258	0.00602	CbGeAlD
Zonisamide—SCN3A—pituitary gland—polycystic ovary syndrome	0.00251	0.00587	CbGeAlD
Zonisamide—SCN3A—adipose tissue—polycystic ovary syndrome	0.0025	0.00585	CbGeAlD
Zonisamide—Dehydration—Metformin—polycystic ovary syndrome	0.00246	0.025	CcSEcCtD
Zonisamide—AOX1—uterus—polycystic ovary syndrome	0.00245	0.00572	CbGeAlD
Zonisamide—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00244	0.0248	CcSEcCtD
Zonisamide—AOX1—pituitary gland—polycystic ovary syndrome	0.0024	0.00562	CbGeAlD
Zonisamide—AOX1—adipose tissue—polycystic ovary syndrome	0.0024	0.0056	CbGeAlD
Zonisamide—MAOA—embryo—polycystic ovary syndrome	0.00239	0.00558	CbGeAlD
Zonisamide—SCN2A—vagina—polycystic ovary syndrome	0.00237	0.00553	CbGeAlD
Zonisamide—CA5B—adrenal gland—polycystic ovary syndrome	0.00231	0.0054	CbGeAlD
Zonisamide—MAOB—adrenal cortex—polycystic ovary syndrome	0.00229	0.00536	CbGeAlD
Zonisamide—Influenza—Metformin—polycystic ovary syndrome	0.00229	0.0232	CcSEcCtD
Zonisamide—CA1—adipose tissue—polycystic ovary syndrome	0.00227	0.00532	CbGeAlD
Zonisamide—SCN3A—adrenal gland—polycystic ovary syndrome	0.00224	0.00525	CbGeAlD
Zonisamide—Pancreatitis—Metformin—polycystic ovary syndrome	0.00224	0.0228	CcSEcCtD
Zonisamide—CA2—embryo—polycystic ovary syndrome	0.00224	0.00522	CbGeAlD
Zonisamide—CA12—endocrine gland—polycystic ovary syndrome	0.00223	0.00522	CbGeAlD
Zonisamide—SCN2A—endocrine gland—polycystic ovary syndrome	0.00222	0.00518	CbGeAlD
Zonisamide—AOX1—adrenal gland—polycystic ovary syndrome	0.00215	0.00502	CbGeAlD
Zonisamide—CA5B—vagina—polycystic ovary syndrome	0.00214	0.005	CbGeAlD
Zonisamide—SCN3A—vagina—polycystic ovary syndrome	0.00208	0.00486	CbGeAlD
Zonisamide—SCN5A—vagina—polycystic ovary syndrome	0.00207	0.00485	CbGeAlD
Zonisamide—MAOB—endometrium—polycystic ovary syndrome	0.00205	0.00479	CbGeAlD
Zonisamide—AOX1—female gonad—polycystic ovary syndrome	0.002	0.00468	CbGeAlD
Zonisamide—CA5B—endocrine gland—polycystic ovary syndrome	0.002	0.00468	CbGeAlD
Zonisamide—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.002	0.0203	CcSEcCtD
Zonisamide—AOX1—vagina—polycystic ovary syndrome	0.00199	0.00465	CbGeAlD
Zonisamide—MAOA—adrenal cortex—polycystic ovary syndrome	0.00196	0.00457	CbGeAlD
Zonisamide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00193	0.0196	CcSEcCtD
Zonisamide—MAOB—uterus—polycystic ovary syndrome	0.00189	0.00441	CbGeAlD
Zonisamide—Bradycardia—Metformin—polycystic ovary syndrome	0.00186	0.0189	CcSEcCtD
Zonisamide—AOX1—endocrine gland—polycystic ovary syndrome	0.00186	0.00435	CbGeAlD
Zonisamide—MAOB—pituitary gland—polycystic ovary syndrome	0.00185	0.00433	CbGeAlD
Zonisamide—MAOB—adipose tissue—polycystic ovary syndrome	0.00185	0.00431	CbGeAlD
Zonisamide—Rhinitis—Metformin—polycystic ovary syndrome	0.00184	0.0187	CcSEcCtD
Zonisamide—CA2—adrenal cortex—polycystic ovary syndrome	0.00183	0.00428	CbGeAlD
Zonisamide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0018	0.0183	CcSEcCtD
Zonisamide—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0018	0.0183	CcSEcCtD
Zonisamide—CA4—pituitary gland—polycystic ovary syndrome	0.00178	0.00417	CbGeAlD
Zonisamide—CA4—adipose tissue—polycystic ovary syndrome	0.00178	0.00416	CbGeAlD
Zonisamide—CA1—endocrine gland—polycystic ovary syndrome	0.00177	0.00414	CbGeAlD
Zonisamide—MAOA—endometrium—polycystic ovary syndrome	0.00175	0.00408	CbGeAlD
Zonisamide—Eye disorder—Metformin—polycystic ovary syndrome	0.00171	0.0174	CcSEcCtD
Zonisamide—MAOB—adrenal gland—polycystic ovary syndrome	0.00166	0.00387	CbGeAlD
Zonisamide—Immune system disorder—Metformin—polycystic ovary syndrome	0.00165	0.0168	CcSEcCtD
Zonisamide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00165	0.0168	CcSEcCtD
Zonisamide—MAOA—uterus—polycystic ovary syndrome	0.00161	0.00376	CbGeAlD
Zonisamide—CA4—adrenal gland—polycystic ovary syndrome	0.00159	0.00373	CbGeAlD
Zonisamide—Malnutrition—Metformin—polycystic ovary syndrome	0.00159	0.0162	CcSEcCtD
Zonisamide—MAOA—pituitary gland—polycystic ovary syndrome	0.00158	0.0037	CbGeAlD
Zonisamide—MAOA—adipose tissue—polycystic ovary syndrome	0.00157	0.00368	CbGeAlD
Zonisamide—Flatulence—Metformin—polycystic ovary syndrome	0.00157	0.016	CcSEcCtD
Zonisamide—Dysgeusia—Metformin—polycystic ovary syndrome	0.00156	0.0159	CcSEcCtD
Zonisamide—MAOB—female gonad—polycystic ovary syndrome	0.00154	0.00361	CbGeAlD
Zonisamide—MAOB—vagina—polycystic ovary syndrome	0.00153	0.00359	CbGeAlD
Zonisamide—Muscle spasms—Metformin—polycystic ovary syndrome	0.00153	0.0156	CcSEcCtD
Zonisamide—Tremor—Metformin—polycystic ovary syndrome	0.00149	0.0152	CcSEcCtD
Zonisamide—CA4—female gonad—polycystic ovary syndrome	0.00149	0.00348	CbGeAlD
Zonisamide—CA2—pituitary gland—polycystic ovary syndrome	0.00148	0.00346	CbGeAlD
Zonisamide—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00148	0.015	CcSEcCtD
Zonisamide—CA2—adipose tissue—polycystic ovary syndrome	0.00147	0.00345	CbGeAlD
Zonisamide—Malaise—Metformin—polycystic ovary syndrome	0.00144	0.0146	CcSEcCtD
Zonisamide—MAOB—endocrine gland—polycystic ovary syndrome	0.00144	0.00336	CbGeAlD
Zonisamide—Syncope—Metformin—polycystic ovary syndrome	0.00143	0.0145	CcSEcCtD
Zonisamide—MAOA—adrenal gland—polycystic ovary syndrome	0.00141	0.0033	CbGeAlD
Zonisamide—Palpitations—Metformin—polycystic ovary syndrome	0.00141	0.0143	CcSEcCtD
Zonisamide—Loss of consciousness—Metformin—polycystic ovary syndrome	0.0014	0.0142	CcSEcCtD
Zonisamide—CA4—endocrine gland—polycystic ovary syndrome	0.00138	0.00323	CbGeAlD
Zonisamide—Hypertension—Metformin—polycystic ovary syndrome	0.00138	0.014	CcSEcCtD
Zonisamide—Myalgia—Metformin—polycystic ovary syndrome	0.00136	0.0138	CcSEcCtD
Zonisamide—Chest pain—Metformin—polycystic ovary syndrome	0.00136	0.0138	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00135	0.0137	CcSEcCtD
Zonisamide—Discomfort—Metformin—polycystic ovary syndrome	0.00134	0.0136	CcSEcCtD
Zonisamide—CYP2C19—vagina—polycystic ovary syndrome	0.00134	0.00313	CbGeAlD
Zonisamide—CA2—adrenal gland—polycystic ovary syndrome	0.00132	0.00309	CbGeAlD
Zonisamide—MAOA—female gonad—polycystic ovary syndrome	0.00132	0.00308	CbGeAlD
Zonisamide—MAOA—vagina—polycystic ovary syndrome	0.00131	0.00306	CbGeAlD
Zonisamide—Oedema—Metformin—polycystic ovary syndrome	0.0013	0.0132	CcSEcCtD
Zonisamide—Infection—Metformin—polycystic ovary syndrome	0.00129	0.0131	CcSEcCtD
Zonisamide—Shock—Metformin—polycystic ovary syndrome	0.00128	0.013	CcSEcCtD
Zonisamide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00128	0.013	CcSEcCtD
Zonisamide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00127	0.0129	CcSEcCtD
Zonisamide—Skin disorder—Metformin—polycystic ovary syndrome	0.00126	0.0128	CcSEcCtD
Zonisamide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00126	0.0128	CcSEcCtD
Zonisamide—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00125	0.00292	CbGeAlD
Zonisamide—Anorexia—Metformin—polycystic ovary syndrome	0.00124	0.0126	CcSEcCtD
Zonisamide—CA2—female gonad—polycystic ovary syndrome	0.00123	0.00288	CbGeAlD
Zonisamide—CA2—vagina—polycystic ovary syndrome	0.00123	0.00286	CbGeAlD
Zonisamide—MAOA—endocrine gland—polycystic ovary syndrome	0.00122	0.00286	CbGeAlD
Zonisamide—Hypotension—Metformin—polycystic ovary syndrome	0.00122	0.0124	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00119	0.012	CcSEcCtD
Zonisamide—Paraesthesia—Metformin—polycystic ovary syndrome	0.00117	0.0119	CcSEcCtD
Zonisamide—Dyspnoea—Metformin—polycystic ovary syndrome	0.00116	0.0118	CcSEcCtD
Zonisamide—Somnolence—Metformin—polycystic ovary syndrome	0.00116	0.0117	CcSEcCtD
Zonisamide—CA2—endocrine gland—polycystic ovary syndrome	0.00115	0.00268	CbGeAlD
Zonisamide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00115	0.0116	CcSEcCtD
Zonisamide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00113	0.0115	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00112	0.0114	CcSEcCtD
Zonisamide—Fatigue—Metformin—polycystic ovary syndrome	0.00112	0.0114	CcSEcCtD
Zonisamide—Constipation—Metformin—polycystic ovary syndrome	0.00111	0.0113	CcSEcCtD
Zonisamide—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00107	0.0109	CcSEcCtD
Zonisamide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00106	0.0108	CcSEcCtD
Zonisamide—Urticaria—Metformin—polycystic ovary syndrome	0.00103	0.0105	CcSEcCtD
Zonisamide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00103	0.0104	CcSEcCtD
Zonisamide—Asthenia—Metformin—polycystic ovary syndrome	0.000934	0.00948	CcSEcCtD
Zonisamide—Pruritus—Metformin—polycystic ovary syndrome	0.000921	0.00935	CcSEcCtD
Zonisamide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00089	0.00904	CcSEcCtD
Zonisamide—Dizziness—Metformin—polycystic ovary syndrome	0.00086	0.00874	CcSEcCtD
Zonisamide—Vomiting—Metformin—polycystic ovary syndrome	0.000827	0.0084	CcSEcCtD
Zonisamide—Rash—Metformin—polycystic ovary syndrome	0.00082	0.00833	CcSEcCtD
Zonisamide—Dermatitis—Metformin—polycystic ovary syndrome	0.00082	0.00833	CcSEcCtD
Zonisamide—Headache—Metformin—polycystic ovary syndrome	0.000815	0.00828	CcSEcCtD
Zonisamide—Nausea—Metformin—polycystic ovary syndrome	0.000773	0.00785	CcSEcCtD
Zonisamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00074	0.00173	CbGeAlD
Zonisamide—CA9—Metabolism—CYP11A1—polycystic ovary syndrome	8.7e-05	0.000184	CbGpPWpGaD
Zonisamide—CA4—Metabolism—TH—polycystic ovary syndrome	8.66e-05	0.000183	CbGpPWpGaD
Zonisamide—AOX1—Disease—PRL—polycystic ovary syndrome	8.65e-05	0.000183	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—YAP1—polycystic ovary syndrome	8.64e-05	0.000182	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CYP1A1—polycystic ovary syndrome	8.64e-05	0.000182	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CYP1A1—polycystic ovary syndrome	8.64e-05	0.000182	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—MTHFR—polycystic ovary syndrome	8.63e-05	0.000182	CbGpPWpGaD
Zonisamide—CA6—Metabolism—MTHFR—polycystic ovary syndrome	8.63e-05	0.000182	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—STAR—polycystic ovary syndrome	8.6e-05	0.000181	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.56e-05	0.000181	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—VEGFA—polycystic ovary syndrome	8.48e-05	0.000179	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.44e-05	0.000178	CbGpPWpGaD
Zonisamide—CA12—Metabolism—NCOR1—polycystic ovary syndrome	8.44e-05	0.000178	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	8.44e-05	0.000178	CbGpPWpGaD
Zonisamide—CA4—Metabolism—SLC2A4—polycystic ovary syndrome	8.42e-05	0.000178	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	8.33e-05	0.000176	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NAMPT—polycystic ovary syndrome	8.3e-05	0.000175	CbGpPWpGaD
Zonisamide—CA2—Metabolism—TH—polycystic ovary syndrome	8.3e-05	0.000175	CbGpPWpGaD
Zonisamide—CACNA1G—Axon guidance—IL6—polycystic ovary syndrome	8.21e-05	0.000173	CbGpPWpGaD
Zonisamide—CA9—Metabolism—AKR1C3—polycystic ovary syndrome	8.21e-05	0.000173	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—VEGFA—polycystic ovary syndrome	8.21e-05	0.000173	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP11A1—polycystic ovary syndrome	8.2e-05	0.000173	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	8.1e-05	0.000171	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP17A1—polycystic ovary syndrome	8.08e-05	0.000171	CbGpPWpGaD
Zonisamide—CA2—Metabolism—SLC2A4—polycystic ovary syndrome	8.07e-05	0.00017	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—VEGFA—polycystic ovary syndrome	8.06e-05	0.00017	CbGpPWpGaD
Zonisamide—CA7—Metabolism—MTHFR—polycystic ovary syndrome	8.05e-05	0.00017	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—MTHFR—polycystic ovary syndrome	8.05e-05	0.00017	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CYP1A1—polycystic ovary syndrome	8e-05	0.000169	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	7.97e-05	0.000168	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	7.96e-05	0.000168	CbGpPWpGaD
Zonisamide—CA1—Metabolism—TH—polycystic ovary syndrome	7.96e-05	0.000168	CbGpPWpGaD
Zonisamide—CACNA1H—Axon guidance—IL6—polycystic ovary syndrome	7.96e-05	0.000168	CbGpPWpGaD
Zonisamide—CACNA1I—Developmental Biology—IL6—polycystic ovary syndrome	7.95e-05	0.000168	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	7.95e-05	0.000168	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP19A1—polycystic ovary syndrome	7.92e-05	0.000167	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	7.85e-05	0.000166	CbGpPWpGaD
Zonisamide—SCN9A—Axon guidance—IL6—polycystic ovary syndrome	7.81e-05	0.000165	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—TH—polycystic ovary syndrome	7.8e-05	0.000165	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	7.77e-05	0.000164	CbGpPWpGaD
Zonisamide—CA1—Metabolism—SLC2A4—polycystic ovary syndrome	7.74e-05	0.000163	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—AKR1C3—polycystic ovary syndrome	7.74e-05	0.000163	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—VEGFA—polycystic ovary syndrome	7.71e-05	0.000163	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	7.68e-05	0.000162	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HMMR—polycystic ovary syndrome	7.66e-05	0.000162	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP17A1—polycystic ovary syndrome	7.62e-05	0.000161	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—SLC2A4—polycystic ovary syndrome	7.59e-05	0.00016	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP19A1—polycystic ovary syndrome	7.59e-05	0.00016	CbGpPWpGaD
Zonisamide—SCN11A—Developmental Biology—IL6—polycystic ovary syndrome	7.54e-05	0.000159	CbGpPWpGaD
Zonisamide—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	7.47e-05	0.000158	CbGpPWpGaD
Zonisamide—CA12—Metabolism—MTHFR—polycystic ovary syndrome	7.46e-05	0.000157	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	7.43e-05	0.000157	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	7.41e-05	0.000156	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—VEGFA—polycystic ovary syndrome	7.41e-05	0.000156	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HSD3B1—polycystic ovary syndrome	7.31e-05	0.000154	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP19A1—polycystic ovary syndrome	7.28e-05	0.000154	CbGpPWpGaD
Zonisamide—AOX1—Disease—NCOR1—polycystic ovary syndrome	7.25e-05	0.000153	CbGpPWpGaD
Zonisamide—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	7.18e-05	0.000152	CbGpPWpGaD
Zonisamide—SCN4A—Axon guidance—IL6—polycystic ovary syndrome	7.18e-05	0.000152	CbGpPWpGaD
Zonisamide—CA14—Metabolism—PPARG—polycystic ovary syndrome	7.18e-05	0.000152	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	7.14e-05	0.000151	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP19A1—polycystic ovary syndrome	7.14e-05	0.000151	CbGpPWpGaD
Zonisamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	7.13e-05	0.00015	CbGpPWpGaD
Zonisamide—AOX1—Disease—NRG1—polycystic ovary syndrome	7.11e-05	0.00015	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	7.08e-05	0.00015	CbGpPWpGaD
Zonisamide—CA14—Metabolism—POMC—polycystic ovary syndrome	7.08e-05	0.000149	CbGpPWpGaD
Zonisamide—CA4—Metabolism—GNAS—polycystic ovary syndrome	7.07e-05	0.000149	CbGpPWpGaD
Zonisamide—CA14—Metabolism—INS—polycystic ovary syndrome	7.04e-05	0.000149	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	7.04e-05	0.000149	CbGpPWpGaD
Zonisamide—CA6—Metabolism—PPARG—polycystic ovary syndrome	7e-05	0.000148	CbGpPWpGaD
Zonisamide—CA9—Metabolism—TH—polycystic ovary syndrome	7e-05	0.000148	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—PPARG—polycystic ovary syndrome	7e-05	0.000148	CbGpPWpGaD
Zonisamide—CA9—Cellular responses to stress—IL6—polycystic ovary syndrome	6.93e-05	0.000146	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	6.92e-05	0.000146	CbGpPWpGaD
Zonisamide—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	6.92e-05	0.000146	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—POMC—polycystic ovary syndrome	6.9e-05	0.000146	CbGpPWpGaD
Zonisamide—CA6—Metabolism—POMC—polycystic ovary syndrome	6.9e-05	0.000146	CbGpPWpGaD
Zonisamide—CA6—Metabolism—INS—polycystic ovary syndrome	6.86e-05	0.000145	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—INS—polycystic ovary syndrome	6.86e-05	0.000145	CbGpPWpGaD
Zonisamide—CA9—Metabolism—SLC2A4—polycystic ovary syndrome	6.8e-05	0.000144	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	6.79e-05	0.000143	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	6.79e-05	0.000143	CbGpPWpGaD
Zonisamide—CA2—Metabolism—GNAS—polycystic ovary syndrome	6.78e-05	0.000143	CbGpPWpGaD
Zonisamide—CA4—Metabolism—NCOR1—polycystic ovary syndrome	6.73e-05	0.000142	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	6.71e-05	0.000142	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—LHB—polycystic ovary syndrome	6.67e-05	0.000141	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—TH—polycystic ovary syndrome	6.59e-05	0.000139	CbGpPWpGaD
Zonisamide—CA7—Metabolism—PPARG—polycystic ovary syndrome	6.53e-05	0.000138	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—PPARG—polycystic ovary syndrome	6.53e-05	0.000138	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—HSD3B2—polycystic ovary syndrome	6.51e-05	0.000138	CbGpPWpGaD
Zonisamide—CA1—Metabolism—GNAS—polycystic ovary syndrome	6.5e-05	0.000137	CbGpPWpGaD
Zonisamide—CA2—Metabolism—NCOR1—polycystic ovary syndrome	6.45e-05	0.000136	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—POMC—polycystic ovary syndrome	6.44e-05	0.000136	CbGpPWpGaD
Zonisamide—CA7—Metabolism—POMC—polycystic ovary syndrome	6.44e-05	0.000136	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—SLC2A4—polycystic ovary syndrome	6.41e-05	0.000135	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—INS—polycystic ovary syndrome	6.41e-05	0.000135	CbGpPWpGaD
Zonisamide—CA7—Metabolism—INS—polycystic ovary syndrome	6.41e-05	0.000135	CbGpPWpGaD
Zonisamide—AOX1—Disease—MTHFR—polycystic ovary syndrome	6.4e-05	0.000135	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP19A1—polycystic ovary syndrome	6.4e-05	0.000135	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP1A1—polycystic ovary syndrome	6.38e-05	0.000135	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—GNAS—polycystic ovary syndrome	6.37e-05	0.000134	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	6.31e-05	0.000133	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKR1C1—polycystic ovary syndrome	6.31e-05	0.000133	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.3e-05	0.000133	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	6.29e-05	0.000133	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	6.25e-05	0.000132	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.21e-05	0.000131	CbGpPWpGaD
Zonisamide—CA1—Metabolism—NCOR1—polycystic ovary syndrome	6.19e-05	0.000131	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	6.17e-05	0.00013	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP1A1—polycystic ovary syndrome	6.12e-05	0.000129	CbGpPWpGaD
Zonisamide—AOX1—Disease—IRS2—polycystic ovary syndrome	6.09e-05	0.000129	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—NCOR1—polycystic ovary syndrome	6.07e-05	0.000128	CbGpPWpGaD
Zonisamide—CA12—Metabolism—PPARG—polycystic ovary syndrome	6.05e-05	0.000128	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP19A1—polycystic ovary syndrome	6.03e-05	0.000127	CbGpPWpGaD
Zonisamide—CA12—Metabolism—POMC—polycystic ovary syndrome	5.97e-05	0.000126	CbGpPWpGaD
Zonisamide—CA4—Metabolism—MTHFR—polycystic ovary syndrome	5.95e-05	0.000126	CbGpPWpGaD
Zonisamide—CA12—Metabolism—INS—polycystic ovary syndrome	5.93e-05	0.000125	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP1A1—polycystic ovary syndrome	5.87e-05	0.000124	CbGpPWpGaD
Zonisamide—CACNA1G—Developmental Biology—IL6—polycystic ovary syndrome	5.86e-05	0.000124	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SULT2A1—polycystic ovary syndrome	5.81e-05	0.000123	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	5.76e-05	0.000122	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP1A1—polycystic ovary syndrome	5.75e-05	0.000121	CbGpPWpGaD
Zonisamide—CA9—Metabolism—GNAS—polycystic ovary syndrome	5.71e-05	0.000121	CbGpPWpGaD
Zonisamide—CA2—Metabolism—MTHFR—polycystic ovary syndrome	5.7e-05	0.00012	CbGpPWpGaD
Zonisamide—CACNA1H—Developmental Biology—IL6—polycystic ovary syndrome	5.68e-05	0.00012	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—RRM2—polycystic ovary syndrome	5.62e-05	0.000119	CbGpPWpGaD
Zonisamide—SCN9A—Developmental Biology—IL6—polycystic ovary syndrome	5.58e-05	0.000118	CbGpPWpGaD
Zonisamide—CA1—Metabolism—MTHFR—polycystic ovary syndrome	5.47e-05	0.000115	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	5.47e-05	0.000115	CbGpPWpGaD
Zonisamide—CA9—Metabolism—NCOR1—polycystic ovary syndrome	5.44e-05	0.000115	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—YAP1—polycystic ovary syndrome	5.42e-05	0.000114	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—GNAS—polycystic ovary syndrome	5.38e-05	0.000114	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	5.37e-05	0.000113	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	5.37e-05	0.000113	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—MTHFR—polycystic ovary syndrome	5.36e-05	0.000113	CbGpPWpGaD
Zonisamide—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	5.33e-05	0.000113	CbGpPWpGaD
Zonisamide—AOX1—Disease—IRS1—polycystic ovary syndrome	5.32e-05	0.000112	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NAMPT—polycystic ovary syndrome	5.21e-05	0.00011	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	5.16e-05	0.000109	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP1A1—polycystic ovary syndrome	5.16e-05	0.000109	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP11A1—polycystic ovary syndrome	5.14e-05	0.000109	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—NCOR1—polycystic ovary syndrome	5.13e-05	0.000108	CbGpPWpGaD
Zonisamide—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	5.12e-05	0.000108	CbGpPWpGaD
Zonisamide—SCN4A—Developmental Biology—IL6—polycystic ovary syndrome	5.12e-05	0.000108	CbGpPWpGaD
Zonisamide—AOX1—Disease—INS—polycystic ovary syndrome	5.09e-05	0.000108	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	5.08e-05	0.000107	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	5.08e-05	0.000107	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	5.02e-05	0.000106	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.01e-05	0.000106	CbGpPWpGaD
Zonisamide—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	4.94e-05	0.000104	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKT2—polycystic ovary syndrome	4.92e-05	0.000104	CbGpPWpGaD
Zonisamide—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	4.87e-05	0.000103	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP1A1—polycystic ovary syndrome	4.86e-05	0.000103	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—AKR1C3—polycystic ovary syndrome	4.86e-05	0.000103	CbGpPWpGaD
Zonisamide—CA4—Metabolism—PPARG—polycystic ovary syndrome	4.82e-05	0.000102	CbGpPWpGaD
Zonisamide—CA9—Metabolism—MTHFR—polycystic ovary syndrome	4.81e-05	0.000101	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP17A1—polycystic ovary syndrome	4.78e-05	0.000101	CbGpPWpGaD
Zonisamide—CA4—Metabolism—POMC—polycystic ovary syndrome	4.76e-05	0.0001	CbGpPWpGaD
Zonisamide—CA4—Metabolism—INS—polycystic ovary syndrome	4.73e-05	9.99e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—SERPINE1—polycystic ovary syndrome	4.68e-05	9.88e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—PPARG—polycystic ovary syndrome	4.63e-05	9.76e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—POMC—polycystic ovary syndrome	4.56e-05	9.63e-05	CbGpPWpGaD
Zonisamide—CA2—Metabolism—INS—polycystic ovary syndrome	4.54e-05	9.58e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—MTHFR—polycystic ovary syndrome	4.53e-05	9.57e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	4.5e-05	9.5e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	4.47e-05	9.43e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—PPARG—polycystic ovary syndrome	4.43e-05	9.36e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—POMC—polycystic ovary syndrome	4.37e-05	9.23e-05	CbGpPWpGaD
Zonisamide—CA1—Metabolism—INS—polycystic ovary syndrome	4.35e-05	9.18e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—PPARG—polycystic ovary syndrome	4.35e-05	9.18e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—POMC—polycystic ovary syndrome	4.29e-05	9.05e-05	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—INS—polycystic ovary syndrome	4.27e-05	9e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	4.27e-05	9e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—TH—polycystic ovary syndrome	4.14e-05	8.73e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	4.08e-05	8.62e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	4.08e-05	8.62e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	4.07e-05	8.59e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—SLC2A4—polycystic ovary syndrome	4.02e-05	8.5e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.02e-05	8.49e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—PPARG—polycystic ovary syndrome	3.9e-05	8.23e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—POMC—polycystic ovary syndrome	3.85e-05	8.12e-05	CbGpPWpGaD
Zonisamide—CA9—Metabolism—INS—polycystic ovary syndrome	3.82e-05	8.07e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.8e-05	8.01e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.79e-05	7.99e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP19A1—polycystic ovary syndrome	3.78e-05	7.99e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—PPARG—polycystic ovary syndrome	3.67e-05	7.76e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	3.63e-05	7.66e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—POMC—polycystic ovary syndrome	3.62e-05	7.65e-05	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—INS—polycystic ovary syndrome	3.6e-05	7.61e-05	CbGpPWpGaD
Zonisamide—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	3.47e-05	7.33e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	3.46e-05	7.3e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	3.42e-05	7.22e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—GNAS—polycystic ovary syndrome	3.38e-05	7.13e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.24e-05	6.84e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	3.23e-05	6.81e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	3.23e-05	6.81e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—NCOR1—polycystic ovary syndrome	3.22e-05	6.79e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	3.15e-05	6.66e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	3.08e-05	6.51e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP1A1—polycystic ovary syndrome	3.05e-05	6.44e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	2.99e-05	6.3e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—MTHFR—polycystic ovary syndrome	2.84e-05	6e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	2.75e-05	5.8e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.71e-05	5.71e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	2.66e-05	5.62e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	2.57e-05	5.42e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.56e-05	5.41e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	2.47e-05	5.2e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.45e-05	5.17e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.45e-05	5.16e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	2.43e-05	5.14e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.42e-05	5.1e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—PPARG—polycystic ovary syndrome	2.31e-05	4.87e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	2.3e-05	4.85e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—POMC—polycystic ovary syndrome	2.27e-05	4.8e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	2.26e-05	4.78e-05	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—INS—polycystic ovary syndrome	2.26e-05	4.77e-05	CbGpPWpGaD
Zonisamide—AOX1—Disease—IL6—polycystic ovary syndrome	2.23e-05	4.7e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.18e-05	4.6e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.08e-05	4.39e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—TH—polycystic ovary syndrome	1.96e-05	4.13e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	1.91e-05	4.02e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.9e-05	4e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.85e-05	3.91e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.8e-05	3.79e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	1.79e-05	3.78e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.65e-05	3.49e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.6e-05	3.38e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	1.6e-05	3.37e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.54e-05	3.26e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	1.52e-05	3.21e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.48e-05	3.13e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.46e-05	3.09e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	1.44e-05	3.05e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.38e-05	2.92e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.36e-05	2.87e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	1.35e-05	2.84e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.18e-05	2.49e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.15e-05	2.42e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	1.09e-05	2.3e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.08e-05	2.27e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	1.08e-05	2.27e-05	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—INS—polycystic ovary syndrome	1.07e-05	2.26e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	9.61e-06	2.03e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	9.16e-06	1.93e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	8.68e-06	1.83e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	8.09e-06	1.71e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.56e-06	1.39e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	6.47e-06	1.37e-05	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	6.44e-06	1.36e-05	CbGpPWpGaD
